Today: 19 June 2026
Browse Category

Earnings Reports 12 January 2026

Kroger maintained its 2026 outlook after first-quarter sales exceeded forecasts, but adjusted earnings missed estimates by a cent. Shares fell in premarket trading due to margin pressure from price investments, higher transport costs, and changes in fuel mix. CarMax reported fiscal Q1 revenue of $8.01 billion, beating forecasts, driven by higher used-car prices and strong wholesale demand, though retail used-vehicle gross profit per unit declined and the company continued price cuts to boost sales. La-Z-Boy shares rebounded nearly 17% in after-hours trading after adjusted earnings beat expectations, with revenue flat year-over-year; retail expansion supported results, but same-store orders and Joybird sales remained weak. Micron Technology shares dropped 3.6% after a record close as semiconductor stocks slipped, with investors locking in profits rather than reacting to specific company news. Netflix shares declined amid deal speculation involving Roku and Lionsgate, with the next earnings date set for July 16; the stock’s outlook depends on ads, pricing, and engagement. AT&T shares dipped 1.23% before a slight premarket uptick, underperforming the broader market as telecom stocks were influenced more by rate changes than company news; its Q2 earnings call is upcoming. Dave & Buster’s shares fell 4.72% after earnings missed on revenue, profit, and comps, raising questions about future sales and free-cash-flow targets. Nokia shares dropped 3.32% in Helsinki after a recent surge, with its ADR slightly up in New York; the company is set to report soon. Ford shares lagged the S&P 500, with the company seeking to continue importing China-built Lincoln Nautilus as new U.S. rules for connected-car software approach.
Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio shares fell 17.7% to $6.62 Monday after announcing a licensing deal with Eisai and releasing initial sales data for its lung-cancer drug. Eisai will pay €50 million upfront for rights outside the U.S., China, and Japan, with further milestone payments possible. Fourth-quarter Ibtrozi sales met estimates, but investors appeared cautious on future prescription growth.
12 January 2026
····
Why Johnson & Johnson stock is up today: new Rybrevant data and earnings ahead

Why Johnson & Johnson stock is up today: new Rybrevant data and earnings ahead

Johnson & Johnson shares rose 2.3% to $209.03 after new data showed its drug Rybrevant, combined with chemotherapy, produced a 51% response rate in metastatic colorectal cancer. The results, from the OrigAMI-1 trial, included a 73% response rate in first-line patients. The company’s fourth-quarter earnings report is due Jan. 21. J&J recently struck a deal with the Trump administration to lower U.S. drug prices.
12 January 2026
···
Procter & Gamble stock rises as defensive staples rally on Powell probe; PG earnings ahead

Procter & Gamble stock rises as defensive staples rally on Powell probe; PG earnings ahead

Procter & Gamble shares rose about 1% to $143.29 Monday afternoon, outpacing the S&P 500’s 0.2% gain as consumer-staples stocks advanced. The move came amid renewed market volatility after news broke of a criminal probe into Fed Chair Jerome Powell. Investors are watching U.S. inflation data and P&G’s Jan. 22 earnings report for further direction.
12 January 2026
··
Pure Storage stock jumps nearly 8% as investor focus turns to insider filing, CPI and a Needham webcast

Pure Storage stock jumps nearly 8% as investor focus turns to insider filing, CPI and a Needham webcast

Pure Storage shares rose 7.9% to $72.29 on Monday, outpacing the broader market. A Friday filing showed founder John Colgrove transferred 200,000 shares as gifts between family trusts. Investors are watching Tuesday’s U.S. CPI report and Pure’s presentation at the Needham Growth Conference on Thursday. Peer stocks, including NetApp and Western Digital, also advanced.
12 January 2026
···
Gold Fields stock jumps as gold breaks $4,600; CPI and earnings in focus

Gold Fields stock jumps as gold breaks $4,600; CPI and earnings in focus

Gold Fields shares surged 6.7% to $48.73 in New York Monday after gold prices hit a record high, prompting gains across gold miners. The rally followed safe-haven buying and a weaker dollar ahead of Tuesday’s U.S. inflation report. Gold Fields earlier touched $49.58, with Newmont, AngloGold Ashanti, and Wheaton Precious Metals also advancing. Investors await CPI data for clues on rates and sector momentum.
12 January 2026
·······
Twist Bioscience stock jumps on early revenue beat as TWST investors eye JPM talk and Feb. 2 results

Twist Bioscience stock jumps on early revenue beat as TWST investors eye JPM talk and Feb. 2 results

Twist Bioscience shares rose nearly 8% Monday after preliminary fiscal Q1 revenue reached about $103.7 million, beating company forecasts. DNA Synthesis and Protein Solutions sales climbed 27% to $51.1 million, while NGS Applications revenue hit $52.6 million. CEO Emily Leproust cited strong demand in both segments. Full audited results are due Feb. 2.
12 January 2026
··
ServiceNow stock steadies after Goldman’s fresh “Buy” call as earnings near

ServiceNow stock steadies after Goldman’s fresh “Buy” call as earnings near

Goldman Sachs initiated coverage of ServiceNow with a Buy rating and a $205 price target Monday, sending shares up 0.2% to around $142 in afternoon trading. The move follows a 3% drop last week. Investors are focused on ServiceNow’s Jan. 28 earnings report for signals on 2026 growth and demand. Stifel recently cut its price target to $200, citing concerns over federal contract trends.
12 January 2026
···
Spotify stock slips as Wall Street digests Fed pressure — CPI and earnings ahead for SPOT

Spotify stock slips as Wall Street digests Fed pressure — CPI and earnings ahead for SPOT

Spotify shares fell 1.2% to $532.97 by midday Monday, underperforming a steady U.S. market as investors eyed political pressure on the Federal Reserve and looming inflation data. The S&P 500-tracking SPY ETF rose 0.1%. Attention is turning to Spotify’s quarterly report on February 10 for updates on subscription pricing and ad demand.
12 January 2026
···
Lumentum stock drops 5% in late morning trade as AI optics bets cool ahead of earnings

Lumentum stock drops 5% in late morning trade as AI optics bets cool ahead of earnings

Lumentum Holdings shares fell 5.4% to $332.28 Monday, underperforming a flat U.S. market. The drop followed news that chief accounting officer Matthew Sepe will step down in early February, with Eric Chang set to replace him. Investors are awaiting Lumentum’s Feb. 3 earnings report and conference call. The stock touched an intraday low of $323.24.
12 January 2026
····
Robinhood (HOOD) stock jumps as bitcoin climbs; traders eye earnings and fresh scrutiny on event contracts

Robinhood (HOOD) stock jumps as bitcoin climbs; traders eye earnings and fresh scrutiny on event contracts

Robinhood shares rose 3.6% to $119.38 by late morning Monday, rebounding after an early drop. Bitcoin gained 1.2% to $92,046, while most crypto-linked stocks were steady. Investors are watching Robinhood’s Feb. 10 earnings and regulatory moves against sports event contracts, a sector the company is expanding into. Tennessee and Connecticut regulators have targeted several firms, including Robinhood, over unlicensed sports wagering.
12 January 2026
····
AST SpaceMobile stock slips in volatile trade as ASTS investors eye next launch steps and earnings

AST SpaceMobile stock slips in volatile trade as ASTS investors eye next launch steps and earnings

AST SpaceMobile shares fell 1.9% to $95.81 Monday after volatile trading, following the December launch of its BlueBird 6 satellite. Investors await the company’s quarterly results in March and updates on satellite deployment. AST aims to launch 45 to 60 satellites by the end of 2026. Other satellite connectivity stocks, including Globalstar and Iridium, rose modestly.
12 January 2026
··
Moderna stock slides as $1.9 billion sales view fails to calm investors (MRNA)

Moderna stock slides as $1.9 billion sales view fails to calm investors (MRNA)

Moderna shares fell 4% to $32.92 Monday after the company raised its 2025 revenue forecast to $1.9 billion and projected operating expenses of up to $5.2 billion. CFO Jamey Mock said U.S. retail vaccination rates dropped 26% in 2025. The company expects about $8.1 billion in year-end cash, including $600 million from a new loan. Investors remain cautious as pandemic demand fades and late-stage vaccine trial results approach.
12 January 2026
···
1 … 149 150 151 152 153 … 257

Stock Market Today

  • Asian Shares Slip After Wall Street Tech Rally Amid U.S.-Iran Deal Delays
    June 19, 2026, 1:28 AM EDT. Asian shares fell on Friday amid thin holiday trading, with Greater China markets closed for the Dragon Boat festival. U.S. futures dropped as hopes dimmed for a swift resolution to U.S.-Iran tensions after postponed talks on Iran's nuclear program and Strait of Hormuz oil flow. Tokyo's Nikkei 225 held steady despite the Bank of Japan's recent interest rate hike to 1%, the highest in three decades, aiming to tackle rising inflation. South Korea's Kospi and Australia's S&P/ASX 200 both declined over 0.5%. On Wall Street, major indexes rebounded with strong gains in technology stocks like Intel, Nvidia, and Micron, lifting the S&P 500 by 1.1%. Oil prices fluctuated but remained above pre-war levels, as the U.S. and Iran signed a deal to end hostilities and reopen shipping lanes.

Latest articles

Kardigan pops in first Nasdaq trading after $400 million IPO

Kardigan pops in first Nasdaq trading after $400 million IPO

19 June 2026
Kardigan surged 37.5% above its $16 IPO price to close at $22 after raising $400 million in an upsized Nasdaq debut, signaling renewed investor appetite for large biotech IPOs as the company advances three late-stage cardiovascular drug candidates.
Go toTop